Comments

Capricor Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Capricor Therapeutics (CAPR) operate in?

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CAPRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$12.86

-1.50-10.45%

At close: -

$13.00

0.141.09%

After Hours: Mar 21, 6:17 PM EDT

Q4 2024 Earnings were released on Wed Mar 19th, after the market close

The most recent conference call was at 16:30 PM, 4 days ago Click to view past webcast

Capricor Therapeutics (CAPR) Forecast

News Earnings Capricor Therapeutics (CAPR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Capricor Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CAPR | Benzinga

Explore Capricor Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CAPR.

Open	$14.16
Close	$12.86
Volume / Avg.	2.66M / 1.18M
Day Range	$12.75 - $14.16
52 Wk Range	3.52 - 23.40
Market Cap	$591.11M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	20.37%
Days to Cover	6.64

Recent News

Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition

FDA grants Priority Review to Capricor's deramiocel for Duchenne cardiomyopathy, setting an August 2025 decision date with no identified review issues.

Vandana Singh

America's Car-Mart Posts Upbeat Sales, Joins Methode Electronics, Verint Systems, Brown-Forman And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$14.16
Close	$12.86
Volume / Avg.	2.66M / 1.18M
Day Range	$12.75 - $14.16
52 Wk Range	3.52 - 23.40
Market Cap	$591.11M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	20.37%
Days to Cover	6.64

About Capricor Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and ex...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Capricor Therapeutics (CAPR) stock?

You can purchase shares of Capricor Therapeutics (NASDAQ:CAPR) through any online brokerage.

View our list of the best stock brokerages

Who are Capricor Therapeutics (CAPR) competitors?

Other companies in Capricor Therapeutics’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN) and Cogent Biosciences (NASDAQ:COGT).

What is the forecast, or price target, for Capricor Therapeutics (CAPR) stock?

Capricor Therapeutics has a consensus price target of $39.29.

What is the current price for Capricor Therapeutics (CAPR)?

The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $13 last updated March 21, 2025 at 6:17 PM EDT.

Does Capricor Therapeutics (CAPR) pay a dividend?

There are no upcoming dividends for Capricor Therapeutics.

When is Capricor Therapeutics (NASDAQ:CAPR) reporting earnings?

Capricor Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Capricor Therapeutics (CAPR) going to split?

There is no upcoming split for Capricor Therapeutics.

What sector and industry does Capricor Therapeutics (CAPR) operate in?

Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.